Tag: Hepatitis
Risk of Diabetes Down With HCV SVR in HIV/HCV Coinfection
Sustained viral response linked to reduction in risk of diabetes, trend toward reduced risk of renal failure
Sorafenib Effect on HCC Survival Depends on Hepatitis Status
Findings in meta-analysis of individual patient data for advanced unresectable hepatocellular carcinoma
Non-Liver-Related Critical Events Down With SVR in HCV+Cirrhosis
Study confirms reduction in critical events, liver-related or not
Ledipasvir-Sofosbuvir Effective for Chronic HCV in Adolescents
98 of 100 patients reached sustained virologic response at 12 weeks; no virologic failure observed
Chronic Hepatitis B Prevalence Higher in Those With T2DM
Findings based on comparison to adult-onset autoimmune diabetes, controls
Diabetes Ups Risk of HCC, Death in Patients With Hepatitis C
Diabetes increases risk of hepatocellular carcinoma development in patients with HCV
Optimal MELD Threshold for HCV Tx Pre-Liver Transplant 23 to 27
Treating HCV before liver transplant increased life expectancy if MELD was ≤27
HOMA2-IR Tied to Hepatocellular Carcinoma Risk in Hepatitis B
HOMA2-IR independently linked to HCC in patients without overt metabolic abnormalities
Ledipasvir-Sofosbuvir Safe for Kidney Recipients With HCV
SVR12 for all kidney transplant recipients with HCV genotype 1, 4 after 12 or 24 weeks of treatment
Probable Interaction ID’d for PrOD, Ribavirin With Warfarin
Case report shows probable interaction for ribavirin with paritaprevir/ritonavir/ombitasvir+dasabuvir
